Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era

B cell lymphoma and multiple myeloma (MM) are the most common hematological malignancies which benefit from therapeutic monoclonal antibodies (mAbs)-based immunotherapies. Despite significant improvement on patient outcome following the use of novel therapies for the past decades, curative treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Tai, Yu-Tzu, Ho, Matthew Zhi Guang, Qiu, Lugui, Anderson, Kenneth C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512936/
https://www.ncbi.nlm.nih.gov/pubmed/28725493
http://dx.doi.org/10.1186/s40164-017-0081-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512936/
https://www.ncbi.nlm.nih.gov/pubmed/28725493
http://dx.doi.org/10.1186/s40164-017-0081-6

Ejemplares similares